BioELife Corp. (LITH)

BioELife Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Cost of Revenue	0	0	0	0	-	0.4
Gross Profit	-0	-0	-0	-0	-	-0.4
Selling, General & Admin	0.09	0.07	0.08	0.1	0.06	0.07
Operating Expenses	0.09	0.07	0.12	0.1	0.06	0.07
Operating Income	-0.09	-0.07	-0.13	-0.1	-0.06	-0.46
Interest Expense	-0.02	-0.08	-0.12	-0.11	-0.04	-0.03
Currency Exchange Gain (Loss)	-0	-0.04	-	-	-	-
EBT Excluding Unusual Items	-0.11	-0.2	-0.25	-0.21	-0.1	-0.5
Gain (Loss) on Sale of Investments	-0.48	-0.82	-	-	-	-
Other Unusual Items	0.68	0.68	-	-	0.02	-
Pretax Income	-0.59	-0.34	-0.25	-0.21	-0.08	-0.5
Net Income	-0.59	-0.34	-0.25	-0.21	-0.08	-0.5
Net Income to Common	-0.59	-0.34	-0.25	-0.21	-0.08	-0.5
Shares Outstanding (Basic)	3	3	2	2	2	1
Shares Outstanding (Diluted)	3	3	2	2	2	1
Shares Change (YoY)	33.70%	6.32%	8.14%	19.67%	67.85%	8.97%
EPS (Basic)	-0.17	-0.13	-0.10	-0.09	-0.04	-0.44
EPS (Diluted)	-0.17	-0.13	-0.10	-0.09	-0.04	-0.44
Free Cash Flow	-0.13	-0.08	-0.12	-0.13	-0.03	-0.04
Free Cash Flow Per Share	-0.04	-0.03	-0.05	-0.06	-0.02	-0.03
EBIT	-0.09	-0.07	-0.13	-0.1	-0.06	-0.46

Source: S&P Capital IQ. Standard template. Financial Sources.